Corporations lock up your genome, while VCs flee biotech

Two posts worth checking out at VentureBeat Life Sciences:

1. Whiz-bang gene technology will soon let you play around with your own genome — but companies like 23andMe and Navigenics may lock it up and repeatedly charge you for access to it. Read about the emerging world of “corporate genomics” here.

2. Funding for biotech and medical-device startups seemed pretty stable in the third quarter, but a closer look revealed that VCs are dropping the sector like a hot potato.